Zelenskyy Informs the Us Congress that their Donations are Actually “Investments”
Volodymyr Zelenskyy, the president of Ukraine, paid a visit to Washington on Wednesday to express gratitude to US authorities and “ordinary Americans” for their assistance in fending off Russia’s invasion and to demand sustained assistance in the challenging months to come. Zelenskyy further said that the money US are spending for Ukraine is not donation, rather an investment.
A Critical Review Meeting Will be Held by PM Modi to Examine the COVID-19 Situation
Today (December 22), the Prime Minister of India, Narendra Modi, is to hold a review meeting to discuss the country’s COVID status. After four confirmed cases of Omicron sub-variant BF.7 across the nation, the high-level emergency meeting was summoned. The variation is responsible for the current dramatic increase of Covid cases in China.
Metro Cash & Carry is Purchased by Reliance Retail for Rs 2,850 Crore
On December 22, Mukesh Ambani’s Reliance Retail Ventures Limited (RRVL), a division of Reliance Industries Ltd, inked binding agreements to pay Rs 2,850 crore in cash for a 100% ownership investment in Metro Cash and Carry India Pvt Ltd (Metro India).
The Moroccan World Cup Team Returns Home to A Hero’s Welcome
To welcome home the national football team, the first Arab or African team to ever make it to the World Cup semifinals, thousands of Moroccans descended on the city on Tuesday. As they were taken from the airport and through center Rabat by dozens of police vehicles, including motorbikes and cars with bright blaring sirens and lights, the team and their coach Walid Regragui waved.
Researchers Identify the Root Cause of the Scent Loss in Extended Covid-19
The discovery offers light on the potential molecular pathways that may be responsible for other lengthy Covid-19 symptoms, such as widespread weariness, shortness of breath, and brain fog, in addition to the lost smell.
T-Cell Defense Against SARS-Cov-2 Omicron Sub-Variants is Still Effective.
Researchers recently reported that sub-lineages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant successfully evade B-cell immune responses by altering neutralizing antibody epitopes in a study that was released to the bioRxiv* preprint server.
